Contact
About Us
Products & Technology
LungFit PH
Pipeline
News & Events
Press Releases
Presentations & Publications
Events
Investors
Stock Data
SEC Filings
Governance
Careers
Contact
Press Releases
Stay
Notified
This is a search field with an auto-suggest feature attached.
Search
There are no suggestions because the search field is empty.
Beyond Air Announces $20.6 Million Private Placement Offering Priced At-the-Market Under Nasdaq Rules
September 27, 2024
Beyond Air to Participate in the 3rd Annual ROTH Healthcare Opportunities Conference
September 23, 2024
Beyond Air® Reports Fiscal First Quarter 2025 Financial Results and Provides Corporate Update
August 6, 2024
Beyond Air® Publishes Peer-Reviewed Journal Article in Scientific Reports with Clinical Data Showing Nitric Oxide was Safe and Beneficial Adjunct Therapy for Subjects with Viral Pneumonia
July 31, 2024
Beyond Air® to Report First Fiscal Quarter 2025 Financial Results on August 6
July 23, 2024
Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024
July 16, 2024
Beyond Air® Reports Fiscal Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
June 24, 2024
Beyond Air® Appoints David Webster as Chief Commercial Officer
June 13, 2024
Beyond Cancer Presents First-in-Class Clinical Data Showing an Immunogenic Response in Subjects with r/r Unresectable Solid Tumors Treated with Ultra-High Concentration Nitric Oxide (UNO)
June 3, 2024
Beyond Air® Schedules Fiscal Year End 2024 Financial Results Conference Call and Webcast
May 23, 2024
Previous
1
2
3
4
5
…
17
Next
Sign up for updates from Beyond Air, Inc.